Prognostic Factors and Outcomes Associated With Neck Lymphedema in Head and Neck Cancer Survivors.
head and neck cancer
lymphedema
patient-reported outcome measures
prognostic factors
quality of life
survivorship
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
revised:
06
02
2024
received:
16
11
2023
accepted:
04
03
2024
medline:
19
3
2024
pubmed:
19
3
2024
entrez:
19
3
2024
Statut:
aheadofprint
Résumé
The purpose of this study is to determine the predictors of neck lymphedema and to explore its association with symptoms and patient-reported outcomes (PROs) in Head and Neck Cancer (HNC) patients who underwent non-operative treatment. This study involved a cross-sectional secondary analysis of data from patients diagnosed with head and neck squamous cell carcinoma who underwent radiation therapy (±chemotherapy). Patients with visits <6 weeks or >2 years following completion of radiation and those with recurrent or metastatic cancer were excluded. Presence of post-treatment lymphedema, demographics, clinical characteristics, health-related behaviors, and symptoms were collected. PROs were obtained using validated questionnaires that assessed depression, anxiety, swallowing dysfunction, and quality of life (QOL). Multivariable regression models were used to examine the relationship between lymphedema with predictors and symptoms. Of the 203 patients included, 88 (43.4%) developed post-treatment lymphedema. In multivariable analysis, pre-treatment Body Mass Index (BMI) (odds ratio [OR] = 1.07, 95% confidence interval [CI] [1.01, 1.14] p = 0.016) and N stage (OR = 1.96, 95% CI [1.06, 3.66], p = 0.032) were found to be independently associated with lymphedema. Regarding PROs, lymphedema was associated with greater swallowing dysfunction (3.48, 95% CI [0.20, 6.75], p = 0.038), decreased mouth opening (-3.70, 95% CI [-7.31, -0.10], p = 0.044), and increased fatigue (1.88, 95% CI [1.05, 3.38], p = 0.034). Higher pre-treatment BMI and greater N stage are identified as independent predictors for lymphedema development in non-operative HNC patients. Additionally, patients experiencing lymphedema reported worsening swallowing dysfunction and increased symptoms related to trismus and fatigue. Recognizing patients at elevated risk for lymphedema allows for early intervention, alleviation of symptom burden, and optimization of health care resources. 4 Laryngoscope, 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.
Références
Tribius S, Raguse M, Voigt C, et al. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: results of a prospective study. Strahlenther Onkol. 2015;191(6):501-510. https://doi.org/10.1007/s00066-015-0824-4.
Deng J, Sinard RJ, Murphy B. Patient experience of head and neck lymphedema therapy: a qualitative study. Support Care Cancer. 2019;27(5):1811-1823. https://doi.org/10.1007/s00520-018-4428-2.
McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Lymphoedema following treatment for head and neck cancer: impact on patients, and beliefs of health professionals. Eur J Cancer Care. 2014;23(3):317-327. https://doi.org/10.1111/ecc.12134.
Tyker A, Franco J, Massa ST, Desai SC, Walen SG. Treatment for lymphedema following head and neck cancer therapy: a systematic review. Am J Otolaryngol. 2019;40(5):761-769. https://doi.org/10.1016/j.amjoto.2019.05.024.
Finnane A, Liu Y, Battistutta D, Janda M, Hayes SC. Lymphedema after breast or gynecological cancer: use and effectiveness of mainstream and complementary therapies. J Altern Complement Med. 2011;17(9):867-869. https://doi.org/10.1089/acm.2010.0456.
Stubblefield MD, Weycker D. Under recognition and treatment of lymphedema in head and neck cancer survivors - a database study [published correction appears in Support Care Cancer. 2023 May 15;31(6):336]. Support Care Cancer. 2023;31(4):229. https://doi.org/10.1007/s00520-023-07698-3.
Ridner SH, Dietrich MS, Niermann K, Cmelak A, Mannion K, Murphy B. A prospective study of the lymphedema and fibrosis continuum in patients with head and neck cancer. Lymphat Res Biol. 2016;14(4):198-205. https://doi.org/10.1089/lrb.2016.0001.
Ugur S, Arıcı C, Yaprak M, et al. Risk factors of breast cancer-related lymphedema. Lymphat Res Biol. 2013;11(2):72-75. https://doi.org/10.1089/lrb.2013.0004.
Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536-3542. https://doi.org/10.1200/JCO.2007.14.4899.
Deng J, Ridner SH, Dietrich MS, et al. Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage. 2012;43(2):244-252. https://doi.org/10.1016/j.jpainsymman.2011.03.019.
Rasmussen JC, Tan IC, Naqvi S, et al. Longitudinal monitoring of the head and neck lymphatics in response to surgery and radiation. Head Neck. 2017;39(6):1177-1188. https://doi.org/10.1002/hed.24750.
Schlichting JA, Pagedar NA, Chioreso C, Lynch CF, Charlton ME. Treatment trends in head and neck cancer: surveillance, epidemiology, and end results (SEER) patterns of care analysis. Cancer Causes Control. 2019;30(7):721-732. https://doi.org/10.1007/s10552-019-01185-z.
Deng J, Ridner SH, Dietrich MS, et al. Factors associated with external and internal lymphedema in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;84(3):e319-e328. https://doi.org/10.1016/j.ijrobp.2012.04.013.
Deng J, Murphy BA, Dietrich MS, et al. Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Head Neck. 2013;35(7):1026-1035. https://doi.org/10.1002/hed.23084.
Deng J, Ridner S, Rothman R, et al. Perceived symptom experience in head and neck cancer patients with lymphedema. J Palliat Med. 2016;19(12):1267-1274. https://doi.org/10.1089/jpm.2016.0174.
Jackson LK, Ridner SH, Deng J, et al. Internal lymphedema correlates with subjective and objective measures of dysphagia in head and neck cancer patients. J Palliat Med. 2016;19(9):949-956. https://doi.org/10.1089/jpm.2016.0018.
Rosenzweig MQ, Althouse AD, Sabik L, et al. The association between area deprivation index and patient-reported outcomes in patients with advanced cancer. Health Equity. 2021;5(1):8-16. https://doi.org/10.1089/heq.2020.0037.
Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg. 2006;35(4):337-342. https://doi.org/10.1016/j.ijom.2005.08.001.
Rogers SN, Lowe D, Yueh B, Weymuller EA Jr. The physical function and social-emotional function subscales of the University of Washington Quality of life questionnaire. Arch Otolaryngol Head Neck Surg. 2010;136(4):352-357. https://doi.org/10.1001/archoto.2010.32.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.
Löwe B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46(3):266-274. https://doi.org/10.1097/MLR.0b013e318160d093.
Belafsky PC, Mouadeb DA, Rees CJ, et al. Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919-924. https://doi.org/10.1177/000348940811701210.
Arrese LC, Carrau R, Plowman EK. Relationship between the eating assessment Tool-10 and objective clinical ratings of swallowing function in individuals with head and neck cancer. Dysphagia. 2017;32(1):83-89. https://doi.org/10.1007/s00455-016-9741-7.
Kaur P, Pannu A, Singh S. Assessment of swallowing and neck dysfunction post radiotherapy/chemo-radiotherapy in head and neck cancer patients. Biom Biostat Int J. 2016;3:66.
Schiefke F, Akdemir M, Weber A, et al. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck. 2009;31:503-512.
Soran A, D'Angelo G, Begovic M, et al. Breast cancer-related lymphedema-what are the significant predictors and how they affect the severity of lymphedema? Breast J. 2006;12(6):536-543. https://doi.org/10.1111/j.1524-4741.2006.00342.x.
Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005;13(11):904-911. https://doi.org/10.1007/s00520-005-0810-y.
Tribius S, Pazdyka H, Tennstedt P, et al. Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio(chemo)therapy- results of a longitudinal study [published online ahead of print, 2020 Jul 2]. Oral Oncol. 2020;109:104856. https://doi.org/10.1016/j.oraloncology.2020.104856.
Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer. 2011;19(6):853-857. https://doi.org/10.1007/s00520-011-1089-9.
Koelmeyer LA, Gaitatzis K, Dietrich MS, et al. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer. 2022;128(18):3408-3415. https://doi.org/10.1002/cncr.34377.
Wuraola F, Olasehinde O, Di Bernardo M, et al. Prevalence and determinants of lymphedema in newly diagnosed Nigerian breast cancer patients using bioimpedance estimations. Ecancermedicalscience. 2023;17:1506. Published 2023 Feb 9. https://doi.org/10.3332/ecancer.2023.1506.
Fu MR, McTernan ML, Qiu JM, et al. Co-occurring fatigue and lymphatic pain incrementally aggravate their negative effects on activities of daily living, emotional distress, and overall health of breast cancer patients. Integr Cancer Ther. 2022;21:15347354221089605.
Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology. 2013;22(7):1466-1484. https://doi.org/10.1002/pon.3201.
Chee S, Byrnes YM, Chorath KT, Rajasekaran K, Deng J. Interventions for Trismus in head and neck cancer patients: a systematic review of randomized controlled trials. Integr Cancer Ther. 2021;20:15347354211006474. https://doi.org/10.1177/15347354211006474.
Jeans C, Brown B, Ward EC, et al. A prospective, longitudinal and exploratory study of head and neck Lymphoedema and dysphagia following Chemoradiotherapy for head and neck cancer. Dysphagia. 2023;38(4):1059-1071. https://doi.org/10.1007/s00455-022-10526-1.
Paskett ED, Stark N. Lymphedema: knowledge, treatment, and impact among breast cancer survivors. Breast J. 2000;6(6):373-378. https://doi.org/10.1046/j.1524-4741.2000.99072.
Anbari AB, Wanchai A, Armer JM. Breast cancer-related lymphedema and quality of life: a qualitative analysis over years of survivorship. Chronic Illn. 2021;17(3):257-268. https://doi.org/10.1177/1742395319872796.
Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177(3):184-188. https://doi.org/10.1016/s0002-9610(99)00008-.